Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Nuclea Biotechnologies
105 South Street
Pittsfield, MA 1201
Phone: 413-749-4705
www.nucleabio.com

Nuclea Biotechnologies is a healthcare company dedicated to the development and commercialization of clinical diagnostic assays identifying gene and protein expression profiles characteristic of an individual's tumor or disease. The firm is committed to advancing discovery and validation of clinical test platforms that are predictive of a cancer patient's responsiveness to oncology therapeutics and the likelihood of disease recurrence.

Key Contact
Name
Patrick Muraca
Title
CEO
Funding Events

Date
Amount
Type
Investors
Valuation
02/02/12 $3,400,000